Shandong Lukang Pharmaceutical Co Ltd
SSE:600789
Wall Street
Price Targets
Price Targets Summary
Shandong Lukang Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Shandong Lukang Pharmaceutical Co Ltd is 12.31 CNY .
Revenue
Forecast
Revenue Estimate
Shandong Lukang Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Shandong Lukang Pharmaceutical Co Ltd's revenue is 12%. The projected CAGR for the next 6 years is -13%.
Net Income
Forecast
Net Income Estimate
Shandong Lukang Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Shandong Lukang Pharmaceutical Co Ltd's net income is 54%. The projected CAGR for the next 6 years is -9%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Shandong Lukang Pharmaceutical Co Ltd's stock price target?
Price Target
12.31
CNY
According to Wall Street analysts, the average 1-year price target for Shandong Lukang Pharmaceutical Co Ltd is 12.31 CNY .
What is Shandong Lukang Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
-13%
For the last 8 years the compound annual growth rate for Shandong Lukang Pharmaceutical Co Ltd's revenue is 12%. The projected CAGR for the next 6 years is -13%.
What is Shandong Lukang Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-9%
For the last 8 years the compound annual growth rate for Shandong Lukang Pharmaceutical Co Ltd's net income is 54%. The projected CAGR for the next 6 years is -9%.